Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

A case report of chronic myelogenous leukemia in a patient with multiple myeloma and a review of the literature.

Ragupathi L, Najfeld V, Chari A, Petersen B, Jagannath S, Mascarenhas J.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):175-9. doi: 10.1016/j.clml.2012.09.010. Epub 2012 Nov 15. Review. No abstract available.

PMID:
23168212
2.

Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma.

Guru Murthy GS, Sawyer J, Alapat D, Samant R, Barlogie B.

Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):e127-9. doi: 10.1016/j.clml.2014.02.008. Epub 2014 Feb 28. No abstract available.

PMID:
24685577
3.

A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.

Ahn S, Park JS, Han JH, Cho SR.

Ann Lab Med. 2015 May;35(3):370-2. doi: 10.3343/alm.2015.35.3.370. Epub 2015 Apr 1. No abstract available.

4.

Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphoid Leukemia during Various Phases of Diseases.

Dolgikh TY, Domnikova NP, Tornuev YV, Vinogradova EV, Krinitsyna YM.

Bull Exp Biol Med. 2017 Feb;162(4):483-487. doi: 10.1007/s10517-017-3645-x. Epub 2017 Feb 27.

PMID:
28239786
5.

Two siblings with chronic myelogenous leukemia.

Kapsali E, Tsiara S, Christou L, Panteli A, Bourantas KL.

J Exp Clin Cancer Res. 2000 Dec;19(4):541-3.

PMID:
11277336
6.

Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.

Junxun L, Junru L, Meilan C, Chujia L, Shaoqian C, Jieyu Z, Zhuangjian Y, Fan Z, Juan O, Jing C, Juan L.

Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000377. Review.

PMID:
26166219
7.

Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.

Horna P, Pantazopoulos P, Lancet JE, Moscinski LC, Zhang L.

Leuk Lymphoma. 2014 Aug;55(8):1952-4. doi: 10.3109/10428194.2013.869330. Epub 2014 Feb 6. No abstract available.

PMID:
24304373
8.

[The combination of chronic myeloid leukemia and multiple myeloma in one patient].

Romanenko NA, Bessmel'tsev SS, Udal'eva VIu, Zenina MN, Martynkevich IS, Rugal' VI, Abdulkadyrov KM.

Vopr Onkol. 2013;59(2):103-10. Russian.

PMID:
23814859
9.
10.

Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.

Nishida H, Yoshimizu N, Ueno H, Fujita A, Kato T, Park JW, Yano T, Tobinai K, Ikeda Y.

Leuk Res. 2007 Mar;31(3):417-8. Epub 2006 May 26. No abstract available.

PMID:
16730062
11.

Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature.

Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, Oizumi K.

Acta Haematol. 1998;99(4):221-3. Review.

PMID:
9644301
12.

Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.

Yanagi M, Shinjo K, Takeshita A, Tobita T, Yano K, Kobayashi M, Terasaki H, Naoe T, Ohnishi K, Ohno R.

Leukemia. 1999 Apr;13(4):542-52.

PMID:
10214860
13.

Safety of a second-generation tyrosine kinase inhibitor and novel targeted therapy for the treatment of a patient with chronic myeloid leukemia and multiple myeloma.

Katzel JA, Lee-Ma A, Vesole DH.

Anticancer Drugs. 2015 Sep;26(8):907-9. doi: 10.1097/CAD.0000000000000262.

PMID:
26111050
14.

Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy.

Mandava N, Costakos D, Bartlett HM.

Arch Ophthalmol. 2005 Apr;123(4):576-7. No abstract available.

PMID:
15824241
15.

Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.

Isoda A, Nakahashi H, Hoshino T, Mitsui T, Yoshida Y.

Am J Hematol. 2007 Jun;82(6):501-2. No abstract available.

16.

Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis.

Acar H, Ecirli S, Gündoğan F, Bulay O, Acar A.

Cancer Genet Cytogenet. 1999 Jan 15;108(2):171-4.

PMID:
9973949
17.

Kappa light chain myeloma with initial cutaneous involvement.

Saka B, Erten N, Oztürk G, Yilmaz C, Dogan O, Buyukbabani N, Besisik SK.

Ann Hematol. 2006 Apr;85(4):272-4. Epub 2006 Jan 20. No abstract available.

PMID:
16425024
18.

Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.

Kata D, Mrówka-Kata K, Seweryn M, Pajak J, Najda J, Kyrcz-Krzemień S.

Leuk Res. 2010 Sep;34(9):e229-31. doi: 10.1016/j.leukres.2010.03.019. Epub 2010 Mar 31. Review. No abstract available.

PMID:
20359744
19.

Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.

Galanopoulos A, Papadhimitriou SI, Kritikou-Griva E, Georgiakaki M, Anagnostopoulos NI.

Ann Hematol. 2009 Mar;88(3):281-2. doi: 10.1007/s00277-008-0597-2. Epub 2008 Aug 26. No abstract available.

PMID:
18726593
20.

Uncommon case of chronic myeloid leukemia with multiple myeloma.

Ide M, Kuwahara N, Matsuishi E, Kimura S, Gondo H.

Int J Hematol. 2010 May;91(4):699-704. doi: 10.1007/s12185-010-0546-4. Epub 2010 Mar 30. Review.

PMID:
20352382

Supplemental Content

Support Center